What makes Nanohale globally unique

Around the world, nanotechnology is gaining broad recognition as one of the most important and promising technologies of the future. The use of nanostructures, such as nanoparticles, enables entirely new material characteristics and behaviors to be achieved, making these structures of great interest for innovative new applications. Particularly within the area of medicine, where expectations for breakthroughs are high, nanotechnology holds out great hope for the future.

One of the most promising of these applications is the use of nano-carriers, which should enable the precisely controlled and highly targeted delivery of powerful drugs while also improving bioavailability. The development and commercialization of these next-generation delivery systems is the core business activity of Nanohale AG. The company’s primary development focus until now has been on proteins and peptides, but oligonucleotides such as siRNA and miRNA also present excellent opportunities for nanocarrier-based formulations.